Maloberti Renaud Bertrand 4
4 · ENDRA Life Sciences Inc. · Filed Dec 11, 2019
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2019-12-11+42,859→ 42,859 totalExercise: $0.90Exp: 2029-12-11→ Common Stock (42,859 underlying)
Footnotes (1)
- [F1]These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date.